Alexion Pharmaceuticals, Inc.

Company Information
Address 352 Knotter Drive
Cheshire, CT, 06410


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Nebulizing Eculizumab for intrapulmonary C5 inhibition

    Amount: $592,000.00

    DESCRIPTION (provided by applicant): The complement component C5 is common to all three pathways of complement activation. Its involvement in the pathogenesis of asthma is controversial. We have recen ...

    SBIRPhase I2005Department of Health and Human Services
  2. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  3. COMPLEMENT ACTIVATION AND MYOCARDIAL INFARCTION

    Amount: $93,760.00

    Coronary artery disease is associated with extensive morbidity and mortality as well as substantial financial cost. An estimated 11.2 million people in the USA have coronary artery disease that leads ...

    SBIRPhase I1997Department of Health and Human Services
  4. Complement Activation and the Platelet Storage Le

    Amount: $734,816.00

    We will systematically examine whether complement activation plays a significant role in theplatelet storage lesion (PSL). The goals of the project are four-fold: (1) to assess the etiology of PSL byd ...

    SBIRPhase II1995Department of Health and Human Services
  5. Generation of Complement Resistant Retroviral Vectors

    Amount: $100,000.00

    The inactivation of retroviral vectors derived from murine cells in human serum represents a formidmany potential applications of in vivo retroviral-mediated gene therapy. We have recently demonstrato ...

    SBIRPhase I1995Department of Health and Human Services
  6. Somatic Cell Gene Therapy for Hemophilia B

    Amount: $74,636.00

    Blood coagulation factor IX is absent or deficient in hemophilia B patients. Current therapy, thetransfusion of human whole blood components, is effective, but it is not prophylactic or free of risk.O ...

    SBIRPhase I1994Department of Health and Human Services
  7. Complement Activation and the Platelet Storage Le

    Amount: $75,000.00

    N/A

    SBIRPhase I1994Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government